Mass Cytometry Analytical Approaches Reveal Cytokine-Induced Changes in Natural Killer Cells

Cytometry Part B - Clinical Cytometry

Volumn 92, Issue 1, 2017, Pages 57-67

  Vendrame, Elena ^a   Fukuyama, Julia ^b   Strauss Albee, Dara M ^b   Holmes, Susan ^b   Blish, Catherine A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

cytokines; IL 15; IL 2; mass cytometry; memory like natural killer cells; natural killer cells

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; GRANZYME; NCR2 PROTEIN, HUMAN;

ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOMETRY; CYTOMETRY BY TIME OF FLIGHT; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE FUNCTION; MASS CYTOMETRY; NATURAL KILLER CELL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; PROCEDURES;

CYTOKINES; FLOW CYTOMETRY; GRANZYMES; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY; KILLER CELLS, NATURAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; PERFORIN;

EID: 85010886827     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21500     Document Type: Article

References (37)

1. Talmadge JE, Phillips H, Schindler J, Tribble H, Pennington R. Systematic preclinical study on the therapeutic properties of recombinant human interleukin 2 for the treatment of metastatic disease. Cancer Res 1987;47:5725–5732.
2. Kobayashi H, Dubois S, Sato N, Sabzevari H, Sakai Y, Waldmann TA, Tagaya Y. Role of trans-cellular IL-15 presentation in the activation of NK cell–mediated killing, which leads to enhanced tumor immunosurveillance. Blood 2005;105:721–727.
3. Cheng M, Chen Y, Xiao W, Sun R, Tian Z. NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 2013;10:230–252.
4. Patidar M, Yadav N, Dalai SK. Interleukin 15: A key cytokine for immunotherapy. Cytokine Growth Factor Rev 2016;1–11.
5. Frederick M, Grimm E, Krohn E, Smid C, Yu TK. Cytokine-induced cytotoxic function expressed by lymphocytes of the innate immune system: Distinguishing characteristics of NK and LAK based on functional and molecular markers. J Interferon Cytokine Res 1997;17:435–447.
6. Kamiya T, Chang YH, Campana D. Expanded and activated natural killer cells for immunotherapy of hepatocellular carcinoma. Cancer Immunol Res 2016;574–581.
7. Varchetta S, Oliviero B, Mavilio D, Mondelli MU. Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity. Cytokine 2013;62:58–63.
8. Paust S, Andrian von UH. Natural killer cell memory. Nat Immunol 2011;131:500–508.
9. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009;457:557–561.
10. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011;331:44–49.
11. Pahl J, Cerwenka A. Tricking the balance: NK cells in anti-cancer immunity. Immunobiology 2015;1–10.
12. Paust S, Senman B, Andrian von UH. Adaptive immune responses mediated by natural killer cells. Immunol. Rev 2010;235:286–296.
13. Paust S, Gill HS, Wang B-Z, Flynn MP, Moseman EA, Senman B, Szczepanik M, Telenti A, Askenase PW, Compans RW, Andrian von UH. Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses. Nat Immunol 2010;11:1127–1135.
14. Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM. Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A 2009;106:1915–1919.
15. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J Exp Med 2012;209:2351–2365.
16. Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004;104:3664–3671.
17. Luetke-Eversloh M, Hammer Q, Durek P, Nordström K, Gasparoni G, Pink M, Hamann A, Walter J, Chang H-D, Dong J, Romagnani C. Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells. PLoS Pathog 2014;10:e1004441.
18. Romee R, Schneider SE, Leong JW, Chase JM, Keppel CR, Sullivan RP, Cooper MA, Fehniger TA. Cytokine activation induces human memory-like NK cells. Blood 2012;120:4751–4760.
19. Amir E-AD, Davis KL, Tadmor MD, Simonds EF, Levine JH, Bendall SC, Shenfeld DK, Krishnaswamy S, Nolan GP, Pe'er D. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol 2013;31:545–552.
20. Qiu P, Simonds EF, Bendall SC, Gibbs KD, Bruggner RV, Linderman MD, Sachs K, Nolan GP, Plevritis SK. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 2011;29:886–891.
21. Spitzer MH, Gherardini PF, Fragiadakis GK, Bhattacharya N, Yuan RT, Hotson AN, Finck R, Carmi Y, Zunder ER, Fantl WJ, Bendall SC, Engleman EG, Nolan GP. An interactive reference framework for modeling a dynamic immune system. Science 2015;349:1259425.
22. Shekhar K, Brodin P, Davis MM, Chakraborty AK. Automatic classification of cellular expression by nonlinear stochastic embedding (ACCENSE). Proc Natl Acad Sci U S A 2014;111:202–207.
23. Bruggner RV, Bodenmiller B, Dill DL, Tibshirani RJ, Nolan GP. Automated identification of stratifying signatures in cellular subpopulations. Proc Natl Acad Sci U S A 2014;111:E2770–E2777.
24. Strauss-Albee DM, Fukuyama J, Liang EC, Yao Y, Jarrell JA, Drake AL, Kinuthia J, Montgomery RR, John-Stewart G, Holmes S, Blish CA. Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Sci Transl Med 2015;7:297ra115.
25. Finck R, Simonds EF, Jager A, Krishnaswamy S, Sachs K, Fantl W, Pe'er D, Nolan GP, Bendall SC. Normalization of mass cytometry data with bead standards. Cytometry a 2013;83A:483–494.
26. Huber W, Heydebreck von A, Sueltmann H, Poustka A, Vingron M. Parameter estimation for the calibration and variance stabilization of microarray data. Stat Appl Genet Mol Biol 2003;2:Article3.
27. Rocke DM, Lorenzato S. A two-component model for measurement. Technometrics 1995;37:176–184.
28. Friedman JH, Rafsky LC. Multivariate generalizations of the wald-wolfowitz and smirnov two-sample tests. Ann Stat 1979;7:697–717.
29. Hsiao C, Liu M, Stanton R, McGee M, Qian Y, Scheuermann RH. Mapping cell populations in flow cytometry data for cross-sample comparison using the Friedman-Rafsky test statistic as a distance measure (Brinkman RR, Aghaeepour N, Finak G, Gottardo R, Mosmann T, Scheuermann RH, editors). Cytometry a 2016;89A:71–88.
30. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR. Interpreting flow cytometry data: A guide for the perplexed. Nat Immunol 2006;7:681–685.
31. Becknell B, Caligiuri MA. Interleukin-2, interleukin-15, and their roles in human natural killer cells. Adv Immunol 2005;86:209–239.
32. Montaldo E, Del Zotto G, Chiesa Della M, Mingari MC, Moretta A, De Maria A, Moretta L. Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. Cytometry a 2013;83A:702–713.
33. De Maria A, Bozzano F, Cantoni C, Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A 2011;108:728–732.
34. Peruzzi G, Femnou L, Gil-Krzewska A, Borrego F, Weck J, Krzewski K, Coligan JE. Membrane-type 6 matrix metalloproteinase regulates the activation-induced downmodulation of CD16 in human primary NK cells. J Immunol 2013;191:1883–1894.
35. Romee R, Foley B, Lenvik T, Wang Y, Zhang B, Ankarlo D, Luo X, Cooley S, Verneris M, Walcheck B, Miller J. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 2013;121:3599–3608.
36. Costanzo MC, Creegan M, Lal KG, Eller MA. OMIP-027: Functional analysis of human natural killer cells. Cytometry a 2015;87A:803–805.
37. Goodier MR, Lusa C, Sherratt S, Rodriguez-Galan A, Behrens R, Riley EM. sustained immune complex-mediated reduction in CD16 expression after vaccination regulates nk cell function. Front Immunol 2016;7:384.